Erytech blasts activist investor's attempt to block reverse merger, Akkadian proposes new board in return
Erytech is duking it out with an activist investor fiercely opposed to its proposed merger with fellow French biotech Pherecydes. After the company fired back at Akkadian Partners’ attempt to block the merger, calling out its “disinformation campaign” and urging other shareholders to support the deal, Akkadian quickly reacted with a proposal of five new board members who can take over if the merger falls through.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.